Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Marked anti-tumor effects of CD8(+)CD62L(+) T cells from melanoma-bearing mice.

Immunological investigations - 1 Jan 2015

Liao Yunmei, Geng Peiliang, Tian Yi, Miao Hongning, Liang Houjie, Zeng Rui, Ni Bing, Ruan Zhihua

Abstract excerpt

CD8(+)CD62L(+) T cells have been shown to play pivotal roles in anti-viral immunity, chronic myeloid leukemia and renal cell carcinoma. Recently, CD8(+)CD62L(+) T cells from naïve mice (nCD8(+)CD62L(+) T cells) have shown superior anti-tumor properties in melanoma-bearing mice. Considering that antigen-specific memory T cells have shown to possess more potent immunity than non-specific memory T cells, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy, Adoptive

Share to L-Selectin

Share to Lymphocyte Count

Share to Lymphocytes, Tumor-Infiltrating

Share to Spleen

Share to T-Lymphocyte Subsets

Source

Identifiers

PMID: 25122543
DOI: 10.3109/08820139.2014.944980

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Marked anti-tumor effects of CD8(+)CD62L(+) T cells from melanoma-bearing mice.PMID 25122543Read ↗

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.Semantic proximity Read ↗

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.Semantic proximity Read ↗

Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy.Semantic proximity Read ↗

Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.Semantic proximity Read ↗

Identification of Melanoma-reactive CD4+ T-Cell Subsets From Human Melanoma Draining Lymph Nodes.Semantic proximity Read ↗

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitroSemantic proximity Read ↗

Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines.Semantic proximity Read ↗

Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells.Semantic proximity Read ↗

Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck cancer patients.Semantic proximity Read ↗

Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.Semantic proximity Read ↗

Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.Semantic proximity Read ↗

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.